Bibliographic Details
| Title: |
Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinoma. |
| Authors: |
Mehboob, Riffat, Kurdi, Maher, Baeesa, Saleh, Halawa, Taher Fawzy, Tanvir, Imrana, Maghrabi, Yazid, Hakamy, Sahar, Saeedi, Rothaina, Moshref, Rana, Nasief, Hisham, Hassan, Amber, Waseem, Humaira, Rasool, Shahida, Bahakeem, Basem, Faizo, Eyad, Katib, Yousef, Bamaga, Ahmed K., Aldardeir, Nashwa |
| Source: |
Folia Neuropathologica; 2022, Vol. 60 Issue 2, p165-176, 12p |
| Abstract: |
Introduction: Neurokinin-1 receptor (NK-1R) induces inflammatory reactions in peripheral tissues but its regulatory effects in target tissues is dependent on receptor signalling. Substance P (SP) has a high affinity for the NK-1R, to which it binds preferentially. We aimed to investigate the expression of NK-1R in World Health Organization (WHO) grade 4 astrocytomas as well as in oral squamous cell carcinoma (OSCC) and urothelial carcinoma, and its association with disease progression. Material and methods: The study included tissue samples from 19 brain astrocytomas, 40 OSCCs and 10 urothelial carcinomas. NK-1R expression was quantitatively assessed in the tumour cells using immunohistochemistry. The relationship between NK-1R expression in astrocytomas and recurrence-free interval has been explored. Results: The results showed that the NK-1R was intensely expressed in patients with WHO grade 4 astrocytoma, OSCC and urothelial carcinoma. However, cases clinically diagnosed as a low-grade cancer showed reduced NK-1R expression. Conclusions: NK-1R is overexpressed in all cases of WHO grade 4 astrocytoma, OSCC and urothelial carcinoma. The ubiquitous presence of SP/NK-1R complex during tumour development and progression suggests a possible therapeutic key strategy to use NK-1R antagonist as an adjuvant therapy in the future. [ABSTRACT FROM AUTHOR] |
|
Copyright of Folia Neuropathologica is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
